IGF-1 Cancer Research Results
IGF-1, insulin-like growth factor-1: Click to Expand ⟱
| Source: |
| Type: |
Higher blood levels of IGF-1, a growth factor, are linked to increased risk of several types of cancer, including thyroid, melanoma and myeloma. IGF-1 is what some call "a growth-promoter" because it has been shown to promote the growth of cancer cells.
The IGF-1 signaling pathway promotes cancer progression; its downregulation is associated with lowered risk.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Melanoma, |
RPMI-8226 |
|
|
|
IGF-1↓, Apoptosis↑, TumCCA↑, MMP↓, Casp3↑, P53↑, BAX↑, Mcl-1↓, EGFR↓, Src↑, KDR/FLK-1↓, p‑IGF-1↓, PI3K↓, Akt↓,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Mitochondria & Bioenergetics ⓘ
MMP↓, 1,
Cell Death ⓘ
Akt↓, 1, Apoptosis↑, 1, BAX↑, 1, Casp3↑, 1, Mcl-1↓, 1,
DNA Damage & Repair ⓘ
P53↑, 1,
Cell Cycle & Senescence ⓘ
TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
IGF-1↓, 1, p‑IGF-1↓, 1, PI3K↓, 1, Src↑, 1,
Angiogenesis & Vasculature ⓘ
EGFR↓, 1, KDR/FLK-1↓, 1,
Clinical Biomarkers ⓘ
EGFR↓, 1,
Total Targets: 15
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: IGF-1, insulin-like growth factor-1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:415 State#:1 Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page